Eye News and Research

Latest Eye News and Research

Migraine can stimulate alcohol-induced headache

Migraine sufferers, beware. You may be more prone to an alcohol-induced headache after a night of drinking, according to researchers from the Jefferson Headache Center.

19 Oct 2009

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

19 Oct 2009

Psychology researchers reveal the importance of peripheral vision

Two Kansas State University psychology researchers have found that although central vision allows our eyes to discern the details of a scene, our peripheral vision is most important for telling us what type of scene we're looking at in the first place, such as whether it is a street, a mountain or a kitchen.

19 Oct 2009

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.

15 Oct 2009

Snowe's vote paves way for other centrists to support Baucus health bill

Before voting with the Democrats on the Senate Finance Committee, Sen. Olympia Snowe, R-Maine, had been involved in negotiations for months that led to the shape of the measure's key elements, USA Today reports.

15 Oct 2009

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

NYU Langone Medical Center has received a five-year, $10 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center for the Neuroscience of Mental Disorders. The center, named after the late Silvio O. Conte, a U.S. congressman and advocate for mental health research, will study the onset of schizophrenia. Schizophrenia is a disease with cognitive dysfunction, affecting approximately one percent of the population worldwide.

15 Oct 2009

Vision scientists identify an intricate process that allows the human eye to adapt quickly to darkness

Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly. The same process also allows the eye to function in bright light.

14 Oct 2009

Wellstar International enters into financing agreement with JMJ Financial

Wellstar International, Inc., has announced that it has entered into a financing agreement with JMJ Financial to provide the Company with an expected $1.2 million dollars in operational funding over the eighteen months. Details of the financing were contained in the Company's Form 8-K filing with the Securities and Exchange Commission on October 9, 2009.

14 Oct 2009

New non-invasive technology to measure glucose levels in the human eye

New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc.

14 Oct 2009

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species -- mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.

14 Oct 2009

Harvard researchers unite in fight against antibiotic resistance

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the "Harvard-wide Program on Antibiotic Resistance."

14 Oct 2009

International Stem Cell launches human cell culture products into commercial research markets

International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human “parthenogenetic” stem cells from unfertilized eggs.

14 Oct 2009

New UCL cancer research centre launched in UK

A new centre is launched in London today (Wednesday), joining a select group of Cancer Research UK Centres across the UK.

14 Oct 2009

States eye budget cuts and health reform

Pennsylvania's hospitals got a small piece of good news when an overdue budget came with smaller than expected cuts. But there and in other states, programs continue to find programs and budgets on the chopping block.

14 Oct 2009

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.

14 Oct 2009

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced that data from a recently completed clinical trial of the LensAR Laser System will be presented at the upcoming 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and Pan-American Academy of Ophthalmology (PAAO). The meeting will be held October 23 - 27, 2009 in San Francisco, CA.

13 Oct 2009

OBP Medical launches cost effective, patient friendly disposable briefs

While walking the road to recovery a patient should at all times feel secure and comfortable in the attire provided to them by their healthcare facility. Here to help is OBP Medical Inc.'s Under Johnnies(TM) Brief with Pad: a cost effective, patient friendly, line of disposable briefs with ultra absorbent padding for patients with post operative bleeding or discharge.

13 Oct 2009

Increasing number of pre-term infants experience eye disorders

As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

In a first-of-its kind procedure, physicians have used stem cells taken from the fat tissue of a 14-year-old boy and combined them with growth protein and donor tissue to grow viable cheek bones in the teen.

13 Oct 2009

Eye News and Research

Latest Eye News and Research

Migraine can stimulate alcohol-induced headache

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

Psychology researchers reveal the importance of peripheral vision

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

Snowe's vote paves way for other centrists to support Baucus health bill

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

Vision scientists identify an intricate process that allows the human eye to adapt quickly to darkness

Wellstar International enters into financing agreement with JMJ Financial

New non-invasive technology to measure glucose levels in the human eye

CeloNova BioSciences' Embozene Microspheres receives approval

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Harvard researchers unite in fight against antibiotic resistance

International Stem Cell launches human cell culture products into commercial research markets

New UCL cancer research centre launched in UK

States eye budget cuts and health reform

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

OBP Medical launches cost effective, patient friendly disposable briefs

Increasing number of pre-term infants experience eye disorders

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Eye News and Research

Latest Eye News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in